Medicare Drug Prices Up Despite Decrease In Prescriptions

With the cost of Medicare drugs a critical issue in healthcare, health insurance companies and government payers need to understand how new and existing drugs compare in terms of benefits and risks. But there's a problem. When drugs are first approved, they have typically been compared in clinical trials to either a placebo or to one standard of care, which is an established treatment that has previously been widely accepted.

Pin It on Pinterest